Total planned funding: $402,011,760
Clear active filters
FHI 360
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Nigeria | $86,902,133 |
Zambia | $61,300,433 |
Mozambique | $58,081,321 |
Kenya | $22,075,956 |
South Africa | $20,923,232 |
Vietnam | $16,590,226 |
Haiti | $12,836,552 |
India | $11,864,357 |
Rwanda | $10,274,213 |
Tanzania | $9,760,431 |
Namibia | $9,623,189 |
Côte d'Ivoire | $9,105,736 |
Burundi | $8,881,411 |
Indonesia | $7,051,794 |
Ghana | $6,982,500 |
Guyana | $6,620,000 |
Ethiopia | $6,526,111 |
Botswana | $4,560,003 |
Zimbabwe | $4,344,201 |
Democratic Republic of the Congo | $3,892,175 |
South Sudan | $3,435,929 |
Asia Regional Program | $3,400,093 |
Malawi | $2,913,446 |
Caribbean Region | $2,525,420 |
Papua New Guinea | $2,486,306 |
Angola | $2,466,719 |
Eswatini | $2,367,187 |
Cambodia | $2,025,000 |
Uganda | $1,945,686 |
Dominican Republic | $250,000 |
Central Asia Region | $0 |
Organizational Types
NGO | $402,011,760 |
Program Areas
Care | $88,682,247 |
Prevention | $75,525,515 |
Treatment | $74,897,794 |
Governance and Systems | $32,619,084 |
Testing | $26,912,039 |
Budget Codes
HTXS: Treatment: Adult Treatment | $64,934,676 |
HVOP: Sexual Prevention: Other Sexual Prevention | $45,595,180 |
HKID: Care: Orphans and Vulnerable Children | $40,039,226 |
HBHC: Care: Adult Care and Support | $32,775,304 |
HVCT: Testing: HIV Testing and Counseling | $26,912,039 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $18,813,150 |
HLAB: Laboratory Infrastructure | $10,919,082 |
HVSI: Strategic Information | $10,878,151 |
OHSS: Health Systems Strengthening | $10,821,851 |
PDTX: Treatment: Pediatric Treatment | $9,963,118 |
PDCS: Care: Pediatric Care and Support | $8,017,697 |
HVTB: Care: TB/HIV | $7,850,020 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $4,150,480 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $3,896,141 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $2,346,451 |
HMBL: Biomedical Prevention: Blood Safety | $391,329 |
HMIN: Biomedical Prevention: Injection Safety | $332,784 |
HTXD: Treatment: ARV Drugs | $0 |
Top Partner Programs
FHI 360:
$402,011,760
View countries